Omeros (OMER) Other Working Capital Changes (2010 - 2026)
Omeros' (OMER) quarterly Other Working Capital Changes came in at -$87000.0 in Q1 2026, down 118.43% year-on-year from $472000.0 in Q1 2025, and down 102.16% quarter-over-quarter from $4.0 million in Q4 2025.
Omeros (OMER) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Omeros has disclosed Other Working Capital Changes across 17 years of filings, most recently posting -$87000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$87000.0, down 118.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $752000.0 (up 114.64% YoY), and the FY2025 annual result was $1.3 million, up 353.58% from the prior year.
- Other Working Capital Changes came in at -$87000.0 for Q1 2026 at Omeros, down from $4.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.1 million in Q1 2024 to a low of -$7.0 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is $462000.0 (2023), against an average of $161823.5.
- Across the five-year window, Other Working Capital Changes tumbled 2113.7% in 2022 and soared 774.57% in 2024, its largest moves.
- Omeros' Other Working Capital Changes stood at $835000.0 in 2022, then jumped by 361.56% to $3.9 million in 2023, then plunged by 69.25% to $1.2 million in 2024, then surged by 239.58% to $4.0 million in 2025, then sank by 102.16% to -$87000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$87000.0 (Q1 2026), $4.0 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87,000.00 |
| Mar 31, 2026 | -87,000.00 |
| Dec 31, 2025 | 4.02 Mn |
| Dec 31, 2025 | 4.02 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Jun 30, 2025 | -787,000.00 |
| Jun 30, 2025 | -787,000.00 |
| Mar 31, 2025 | 472,000.00 |
| Mar 31, 2025 | 472,000.00 |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 188,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | -6.98 Mn |
| Jun 30, 2024 | -6.98 Mn |
| Mar 31, 2024 | 5.09 Mn |
| Mar 31, 2024 | 5.09 Mn |
| Dec 31, 2023 | 3.85 Mn |
| Dec 31, 2023 | 3.85 Mn |